James D. Andya
James D. Andya publishes mostly in Molecular Biology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, on topics such as Protein purification and stability, Monoclonal and Polyclonal Antibodies Research and Viral Infectious Diseases and Gene Expression in Insects.
- World rank
- #1,267,883 of 7,710,434 ranked researchers
- Rank in United States
- #404,299 of 1,627,098
- Works
- 17
- Citations
- 2.1k
- Citations per work
- 121.2
What does James D. Andya research?
James D. Andya's work is mostly in Biochemistry, Genetics and Molecular Biology (49%), Medicine (29%), Agricultural and Biological Sciences (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences1057.1%
- Health Sciences528.6%
- Medicine528.6%
- Everything else210.2%
- Physical Sciences14.1%
- Engineering14.1%
- 1Molecular Biology49% of their works
- 2Radiology, Nuclear Medicine and Imaging20% of their works
- 3Pulmonary and Respiratory Medicine8% of their works
- 4Food Science6% of their works
- 5Biomedical Engineering4% of their works
- 6Immunology2% of their works
Research topics
- Protein purification and stability
- Monoclonal and Polyclonal Antibodies Research
- Viral Infectious Diseases and Gene Expression in Insects
- Inhalation and Respiratory Drug Delivery
- Microencapsulation and Drying Processes
- Glycosylation and Glycoproteins Research
- Microfluidic and Capillary Electrophoresis Applications
- Hemoglobin structure and function
Which keywords describe James D. Andya's research?
The keywords of their largest research topics: Monoclonal Antibodies, Therapeutic Antibodies, Glycosylation, Biopharmaceuticals, Protein Aggregation, Antibody Engineering, Fc Receptors and Mammalian Cells.
- Hemoglobin
- Lab-on-a-Chip
- Glycans
- Cancer
- Inhaler Devices
- Mammalian Cells
- Antibody Engineering
- Biopharmaceuticals
- Therapeutic Antibodies
- Monoclonal Antibodies
- Glycosylation
- Protein Aggregation
- Fc Receptors
- Recombinant Protein
- Pulmonary Drug Delivery
- Encapsulation Techniques
- Spray Drying
- Poly(dimethylsiloxane)
- Scavenger Receptor
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Monoclonal Antibodies252 topics
- Therapeutic Antibodies252 topics
- Glycosylation183 topics
- Biopharmaceuticals151 topic
- Protein Aggregation151 topic
- Antibody Engineering101 topic
- Fc Receptors101 topic
- Mammalian Cells51 topic
- Recombinant Protein51 topic
- Inhaler Devices41 topic
- Pulmonary Drug Delivery41 topic
- Cancer31 topic
- Encapsulation Techniques31 topic
- Glycans31 topic
- Spray Drying31 topic
- Lab-on-a-Chip21 topic
- Poly(dimethylsiloxane)21 topic
- Hemoglobin11 topic
- Scavenger Receptor11 topic
Where does James D. Andya work?
James D. Andya's main affiliation in the publication record is Pharmaceutical Product Development (United States), United States.
How many publications and citations does James D. Andya have?
OpenAlex counts 17 works and 2,060 citations for James D. Andya, an h-index of 13, ranking #1,267,883 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about James D. Andya. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.